FibroBiologics (FBLG) Common Equity (2022 - 2026)
FibroBiologics' Common Equity came in at $4.64 million for Q2 2026, up 439.1% from $860,000 a year earlier and up 78.3% from the prior quarter.
Powered by 
Analysis
FibroBiologics (FBLG) Common Equity (2022 - 2026) Analysis & Trends
At the end of FY2025, FibroBiologics' Common Equity was $6.16 million, up 125.1% from FY2024.
- Going back by year, Common Equity was $2.74 million in FY2024 (+118.3%), $1.25 million in FY2023 and -$4 million in FY2022.
- The five-year range for quarterly Common Equity is -$4 million (Q4 2022) to $11.35 million (Q2 2023).
- Year-over-year, Common Equity has increased for three consecutive quarters, with growth averaging 87.3% over the last six quarters.
- Business Quant data shows FBLG's Common Equity at $2.6 million (Q1 2026), $6.16 million (Q4 2025) and $125,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | FibroBiologics | 6.13 Mn | -8.69 Mn | - | 4.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.64 Mn |
| Mar 31, 2026 | 2.60 Mn |
| Dec 31, 2025 | 6.16 Mn |
| Sep 30, 2025 | 125,000.00 |
| Jun 30, 2025 | 860,000.00 |
| Mar 31, 2025 | 2.35 Mn |
| Dec 31, 2024 | 2.74 Mn |
| Sep 30, 2024 | 2.74 Mn |
| Jun 30, 2024 | -2.39 Mn |
| Mar 31, 2024 | -3.86 Mn |
| Dec 31, 2023 | 1.25 Mn |
| Sep 30, 2023 | 10.54 Mn |
| Jun 30, 2023 | 11.35 Mn |
| Mar 31, 2023 | 639,000.00 |
| Dec 31, 2022 | -4.00 Mn |
API Access
FibroBiologics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=FBLG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "FBLG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=FBLG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();